These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 32202667)

  • 41. Higher levels of total pepsin and bile acids in the saliva as a possible risk factor for early laryngeal cancer.
    Sereg-Bahar M; Jerin A; Hocevar-Boltezar I
    Radiol Oncol; 2015 Mar; 49(1):59-64. PubMed ID: 25810702
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Activity/stability of human pepsin: implications for reflux attributed laryngeal disease.
    Johnston N; Dettmar PW; Bishwokarma B; Lively MO; Koufman JA
    Laryngoscope; 2007 Jun; 117(6):1036-9. PubMed ID: 17417109
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pepsin Promotes Activation of Epidermal Growth Factor Receptor and Downstream Oncogenic Pathways, at Slightly Acidic and Neutral pH, in Exposed Hypopharyngeal Cells.
    Doukas PG; Vageli DP; Sasaki CT; Judson BL
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33924087
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Does gene expression in laryngeal subsites differ between patients with laryngopharyngeal reflux and controls?
    Wood JM; Hussey DJ; Woods CM; Astill D; I Watson D; Lee B; Carney AS
    Clin Otolaryngol; 2018 Feb; 43(1):158-163. PubMed ID: 28620964
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Is Pepsin a Reliable Marker of Laryngopharyngeal Reflux? A Systematic Review.
    Calvo-Henríquez C; Ruano-Ravina A; Vaamonde P; Martínez-Capoccioni G; Martín-Martín C
    Otolaryngol Head Neck Surg; 2017 Sep; 157(3):385-391. PubMed ID: 28585488
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Correlation of salivary and nasal lavage pepsin with MII-pH testing.
    Klimara MJ; Johnston N; Samuels TL; Visotcky AM; Poetker DM; Loehrl TA; Blumin JH; Bock JM
    Laryngoscope; 2020 Apr; 130(4):961-966. PubMed ID: 31329290
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of acid and pepsin on gene expression in laryngeal fibroblasts.
    Ylitalo R; Baugh A; Li W; Thibeault S
    Ann Otol Rhinol Laryngol; 2004 Nov; 113(11):866-71. PubMed ID: 15562895
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Does Pepsin Play a Role in Etiology of Laryngeal Nodules?
    Tasli H; Eser B; Asik MB; Birkent H
    J Voice; 2019 Sep; 33(5):704-707. PubMed ID: 29759919
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pepsin as a biomarker for laryngopharyngeal reflux in children with laryngomalacia.
    Luebke K; Samuels TL; Chelius TH; Sulman CG; McCormick ME; Kerschner JE; Johnston N; Chun RH
    Laryngoscope; 2017 Oct; 127(10):2413-2417. PubMed ID: 28224634
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Is laryngopharyngeal reflux an important risk factor in the development of laryngeal carcinoma?
    Ozlugedik S; Yorulmaz I; Gokcan K
    Eur Arch Otorhinolaryngol; 2006 Apr; 263(4):339-43. PubMed ID: 16252124
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pepsin and oropharyngeal pH monitoring to diagnose patients with laryngopharyngeal reflux.
    Weitzendorfer M; Antoniou SA; Schredl P; Witzel K; Weitzendorfer IC; Majerus A; Emmanuel K; Koch OO
    Laryngoscope; 2020 Jul; 130(7):1780-1786. PubMed ID: 31603541
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Diagnostic Usefullness of the Salivary Pepsin Test in Symptomatic Laryngopharyngeal Reflux.
    Barona-Lleo L; Barona-De Guzman R; Krstulovic C
    J Voice; 2019 Nov; 33(6):923-928. PubMed ID: 30314932
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of pepsin and pepsinogen: linking laryngopharyngeal reflux with otitis media with effusion in children.
    Luo HN; Yang QM; Sheng Y; Wang ZH; Zhang Q; Yan J; Hou J; Zhu K; Cheng Y; Wang BT; Xu YL; Zhang XH; Ren XY; Xu M
    Laryngoscope; 2014 Jul; 124(7):E294-300. PubMed ID: 24284944
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vitro effects of acid and pepsin on mouse middle ear epithelial cell viability and MUC5B gene expression.
    Block BB; Kuo E; Zalzal HG; Escobar H; Rose M; Preciado D
    Arch Otolaryngol Head Neck Surg; 2010 Jan; 136(1):37-42. PubMed ID: 20083776
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation and management of laryngopharyngeal reflux.
    Ford CN
    JAMA; 2005 Sep; 294(12):1534-40. PubMed ID: 16189367
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Rationale for targeting pepsin in the treatment of reflux disease.
    Johnston N; Wells CW; Samuels TL; Blumin JH
    Ann Otol Rhinol Laryngol; 2010 Aug; 119(8):547-58. PubMed ID: 20860281
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evidence of Pepsin-Related Ocular Surface Damage and Dry Eye (PROD Syndrome) in Patients with Laryngopharyngeal Reflux.
    Plateroti R; Sacchetti M; Magliulo G; Plateroti AM; Pace A; Moramarco A; Lambiase A; Bruscolini A
    Life (Basel); 2020 Sep; 10(9):. PubMed ID: 32942541
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The role of Glut-1 and H
    Ao YJ; Wu TT; Cao ZZ; Zhou SH; Bao YY; Shen LF
    Eur Arch Otorhinolaryngol; 2022 Jun; 279(6):2981-2987. PubMed ID: 35083516
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Clinical significance and research progress of pepsin in laryngopharygeal reflux and laryngeal carcinoma].
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Apr; 32(7):559-562. PubMed ID: 29798094
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pepsin Inhibitors Prevent Inflammation and Loss of Laryngeal Barrier Function in Mice with Gastroesophageal Reflux.
    Sales TMAL; Sidou FMNO; da Costa Filho HB; de Melo Nogueira K; Dias Júnior GJ; de Sousa Lima MA; da Silva LMG; Nicolau LAD; Soares PMG; Nobre E Souza MÂ; Sifrim D; de Souza MHLP
    Laryngoscope; 2024 Jul; 134(7):3080-3085. PubMed ID: 38214310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.